Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to...
PromarkerD presented at Australasian Proteomics conference
Proteomics International announces the attached presentation on PromarkerD (MS)# was given yesterday at the 25th Annual Lorne Proteomics Symposium, Lorne Victoria 6-9 February 2020, Australasia’s premier conference on proteomics.
Proteomics International’s Research Manager, Dr. Scott Bringans was invited to speak in the New Technologies session on the company’s pioneering test for predicting the onset of diabetic kidney disease.
